Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: A case report

Journal of Sexual Medicine

Volumn 6, Issue 4, 2009, Pages 1177-1180

  Munhoz, Renato P ^a   Fabiani, Giorgio ^a   Becker, Nilson ^a   Teive, Hélio A G ^a,b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Anal intercourse; Dopamine agonist; Hypersexuality; Parkinson's disease; Pramipexole

Indexed keywords

CARBIDOPA PLUS LEVODOPA; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; SELEGILINE;

AGED; ANUS INTERCOURSE; ARTICLE; CASE REPORT; DISEASE DURATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HYPERSEXUALITY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; REMISSION; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE;

EID: 63849118837     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00861.x     Document Type: Article

References (23)

1. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-53.
2. Adler CH. Nonmotor complications in Parkinson's disease. Mov Disord 2005;20(11 suppl):S23-9.
3. Niremberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006;21:524-9.
4. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006;67:1254-7.
5. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006;67:1258-61.
6. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006;63:969-73.
7. Weintraub D, Potenza MN. Impulse control disorders in Parkinson's disease. Curr Neurol Neurosci Rep 2006;6:302-6.
8. Cannas A, Solla P, Floris G, Tacconi P, Loi D, Marcia E, Marrosu MG. Hypersexual behavior, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide; a rare case of iatrogenic paraphilia. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1539-41.
9. Jiménez-Jiménez FJ, Sayed Y, García-Soldevilla MA, Barcenilla B. Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother 2002;36:1178-9.
10. Goodwin FK. Psychiatric side effects of levodopa in man. JAMA 1971;218:1915-20.
11. Ricci E, Parazzini F, Mirone V, Imbimbo C, Palmieri A, Bortolotti A, Di Cintio E, Landoni M, Lavezzari M. Current drug use as risk factor for erectile dysfunction: Results from an Italian epidemiological study. Int J Impot Res 2003;15:221-4.
12. Vogel HP, Schiffter R. Hypersexuality - a complication of dopaminergic therapy in Parkinson's disease. Pharmacopsychiatria 1983;16:107-10.
13. Berger CH, Mehrhoff FW, Beier KM, Meinck HM. Sexual delinquency and Parkinson's disease. Der Nervenarzt 2003;74:370-5.
14. Shapiro MA, Chang YL, Munson SK, Okun Ms, Fernandez HH. Hypersexuality and paraphilia induced by selegeline in Parkinson's disease: Report of 2 cases. Parkinsonism Relat Disord 2006;12:392-5.
15. Riley DE. Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline. Clin Neuropharmacol 2002;25:234-7.
16. Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinonism Relat Disord 2005;11:381-6.
17. Singh A, Kandimala G, Dewey RB Jr, O'Suilleabhain P. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists. J Clin Neurosci 2007;14:1178-81.
18. Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: The role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 2007;21:501-6.
19. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12:375-83.
20. Driver-Dunckley ED, Noble BN, Hentz JG, Evidente VG, Caviness JN, Parish J, Krahn L, Adler CH. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007;30:249-55.
21. Bechara A, Bertolino MV, Casabé A, Fredotovich N. A double-blind randomized placebo control study comparing the objective and subjective changes in female sexual response using sublingual apomorphine. J Sex Med 2004;1:209-14.
22. Padma-Nathan H, Christ G, Adaikan G, Becher E, Brock G, Carrier S, Carson C, Corbin J, Francis S, DeBusk R, Eardley I, Hedlund H, Hutter A, Jackson G, Kloner R, Lin CS, McVary K, McCullough A, Nehra A, Porst H, Schulman C, Seftel A, Sharlip I, Stief C, Teloken C. Pharmacotherapy for erectile dysfunction. J Sex Med 2004;1:128-40.
23. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002;36:1577-89.